Rock Springs Capital Management as of June 30, 2024
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 110 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Blueprint Medicines (BPMC) | 8.2 | $271M | 2.5M | 107.78 | |
UnitedHealth (UNH) | 4.2 | $140M | 275k | 509.26 | |
Intuitive Surgical Com New (ISRG) | 4.0 | $133M | 299k | 444.85 | |
Neurocrine Biosciences (NBIX) | 3.9 | $129M | 940k | 137.67 | |
Eli Lilly & Co. (LLY) | 3.3 | $110M | 122k | 905.38 | |
Argenx Se Sponsored Adr (ARGX) | 3.0 | $99M | 229k | 430.04 | |
Acadia Healthcare (ACHC) | 2.4 | $80M | 1.2M | 67.54 | |
Ultragenyx Pharmaceutical (RARE) | 2.4 | $79M | 1.9M | 41.10 | |
Evolent Health Cl A (EVH) | 2.3 | $78M | 4.1M | 19.12 | |
Madrigal Pharmaceuticals (MDGL) | 2.1 | $69M | 246k | 280.16 | |
Boston Scientific Corporation (BSX) | 1.9 | $63M | 818k | 77.01 | |
Freshpet (FRPT) | 1.9 | $62M | 480k | 129.39 | |
Alnylam Pharmaceuticals (ALNY) | 1.8 | $61M | 250k | 243.00 | |
Mirum Pharmaceuticals (MIRM) | 1.8 | $61M | 1.8M | 34.19 | |
Merus N V (MRUS) | 1.8 | $59M | 1.0M | 59.17 | |
IDEXX Laboratories (IDXX) | 1.8 | $58M | 120k | 487.20 | |
Agilon Health (AGL) | 1.8 | $58M | 8.9M | 6.54 | |
Dex (DXCM) | 1.7 | $57M | 500k | 113.38 | |
Humana (HUM) | 1.7 | $55M | 147k | 373.65 | |
Insmed Com Par $.01 (INSM) | 1.6 | $54M | 808k | 67.00 | |
Rhythm Pharmaceuticals (RYTM) | 1.6 | $53M | 1.3M | 41.06 | |
Celldex Therapeutics Com New (CLDX) | 1.6 | $52M | 1.4M | 37.01 | |
Phreesia (PHR) | 1.5 | $51M | 2.4M | 21.20 | |
Edwards Lifesciences (EW) | 1.5 | $51M | 550k | 92.37 | |
Xenon Pharmaceuticals (XENE) | 1.5 | $50M | 1.3M | 38.99 | |
West Pharmaceutical Services (WST) | 1.4 | $48M | 146k | 329.39 | |
Penumbra (PEN) | 1.4 | $48M | 265k | 179.97 | |
EXACT Sciences Corporation (EXAS) | 1.4 | $46M | 1.1M | 42.25 | |
Agios Pharmaceuticals (AGIO) | 1.4 | $45M | 1.0M | 43.12 | |
Sarepta Therapeutics (SRPT) | 1.4 | $45M | 284k | 158.00 | |
Irhythm Technologies (IRTC) | 1.3 | $43M | 398k | 107.64 | |
Structure Therapeutics Sponsored Ads Call Option (GPCR) | 1.3 | $42M | 1.1M | 39.27 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $40M | 290k | 136.38 | |
Insulet Corporation (PODD) | 1.2 | $39M | 195k | 201.80 | |
Travere Therapeutics (TVTX) | 1.1 | $37M | 4.5M | 8.22 | |
Brooks Automation (AZTA) | 1.1 | $37M | 696k | 52.62 | |
Revolution Medicines (RVMD) | 1.1 | $37M | 943k | 38.81 | |
Kymera Therapeutics (KYMR) | 1.0 | $35M | 1.2M | 29.85 | |
Mereo Biopharma Group Spon Ads (MREO) | 1.0 | $33M | 9.3M | 3.60 | |
Warby Parker Cl A Com (WRBY) | 1.0 | $33M | 2.1M | 16.06 | |
Immunovant (IMVT) | 0.9 | $31M | 1.2M | 26.40 | |
Align Technology (ALGN) | 0.9 | $31M | 128k | 241.43 | |
Akero Therapeutics (AKRO) | 0.8 | $25M | 1.1M | 23.46 | |
Johnson & Johnson (JNJ) | 0.7 | $25M | 170k | 146.16 | |
Lifestance Health Group (LFST) | 0.7 | $24M | 4.8M | 4.91 | |
Zai Lab Adr (ZLAB) | 0.7 | $23M | 1.3M | 17.33 | |
Pacira Pharmaceuticals (PCRX) | 0.7 | $23M | 785k | 28.61 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.7 | $22M | 506k | 44.29 | |
BioCryst Pharmaceuticals (BCRX) | 0.7 | $22M | 3.6M | 6.18 | |
Novo-nordisk A S Adr (NVO) | 0.6 | $21M | 148k | 142.74 | |
Oscar Health Cl A (OSCR) | 0.6 | $20M | 1.3M | 15.82 | |
Nuvalent Inc-a (NUVL) | 0.6 | $19M | 256k | 75.86 | |
Krystal Biotech (KRYS) | 0.6 | $19M | 106k | 183.64 | |
Inspire Med Sys (INSP) | 0.5 | $17M | 130k | 133.83 | |
Inozyme Pharma (INZY) | 0.5 | $17M | 3.7M | 4.46 | |
Dyne Therapeutics (DYN) | 0.5 | $16M | 461k | 35.29 | |
Dynavax Technologies Corp Com New (DVAX) | 0.4 | $15M | 1.3M | 11.23 | |
Pharvaris N V (PHVS) | 0.4 | $14M | 757k | 18.80 | |
Immunocore Hldgs Ads (IMCR) | 0.4 | $14M | 419k | 33.89 | |
Vera Therapeutics Cl A (VERA) | 0.4 | $14M | 381k | 36.18 | |
Crinetics Pharmaceuticals In (CRNX) | 0.4 | $13M | 289k | 44.79 | |
Prothena Corp SHS (PRTA) | 0.4 | $13M | 625k | 20.64 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.4 | $13M | 500k | 25.48 | |
Charles River Laboratories (CRL) | 0.4 | $12M | 60k | 206.58 | |
BioMarin Pharmaceutical (BMRN) | 0.4 | $12M | 151k | 82.33 | |
Amicus Therapeutics (FOLD) | 0.4 | $12M | 1.2M | 9.92 | |
Nevro (NVRO) | 0.4 | $12M | 1.4M | 8.42 | |
Cullinan Oncology (CGEM) | 0.3 | $12M | 658k | 17.44 | |
Enliven Therapeutics (ELVN) | 0.3 | $10M | 429k | 23.37 | |
Jasper Therapeutics Com New (JSPR) | 0.3 | $9.2M | 404k | 22.70 | |
Novavax Com New (NVAX) | 0.3 | $8.5M | 675k | 12.66 | |
Accolade (ACCD) | 0.2 | $8.2M | 2.3M | 3.58 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.2 | $8.0M | 1.5M | 5.44 | |
Springworks Therapeutics (SWTX) | 0.2 | $7.5M | 200k | 37.67 | |
Neumora Therapeutics (NMRA) | 0.2 | $7.5M | 760k | 9.83 | |
Applied Therapeutics (APLT) | 0.2 | $7.3M | 1.6M | 4.67 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $6.7M | 1.2M | 5.71 | |
Mersana Therapeutics (MRSN) | 0.2 | $6.1M | 3.0M | 2.01 | |
Beam Therapeutics (BEAM) | 0.2 | $5.9M | 250k | 23.43 | |
Acumen Pharmaceuticals (ABOS) | 0.2 | $5.6M | 2.3M | 2.42 | |
Compass Therapeutics (CMPX) | 0.2 | $5.5M | 5.5M | 1.00 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $5.4M | 141k | 38.36 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.1 | $4.7M | 9.6M | 0.49 | |
Fulcrum Therapeutics (FULC) | 0.1 | $4.5M | 728k | 6.20 | |
Macrogenics (MGNX) | 0.1 | $4.5M | 1.1M | 4.25 | |
Mineralys Therapeutics (MLYS) | 0.1 | $4.4M | 379k | 11.70 | |
Biohaven (BHVN) | 0.1 | $4.4M | 128k | 34.71 | |
Pliant Therapeutics (PLRX) | 0.1 | $4.1M | 385k | 10.75 | |
Pulmonx Corp (LUNG) | 0.1 | $4.1M | 652k | 6.34 | |
Perspective Therapeutics Com New (CATX) | 0.1 | $4.0M | 401k | 9.97 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.1 | $3.6M | 1.0M | 3.48 | |
Essa Pharma Com New (EPIX) | 0.1 | $3.6M | 677k | 5.26 | |
Aclaris Therapeutics (ACRS) | 0.1 | $3.0M | 2.8M | 1.10 | |
Gossamer Bio (GOSS) | 0.1 | $2.9M | 3.3M | 0.90 | |
Travere Therapeutics Note 2.500% 9/1 (Principal) | 0.1 | $2.9M | 3.3M | 0.89 | |
Xilio Therapeutics (XLO) | 0.1 | $2.8M | 3.0M | 0.95 | |
Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $2.7M | 788k | 3.42 | |
Leap Therapeutics Com New (LPTX) | 0.1 | $2.5M | 1.3M | 1.96 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $2.4M | 2.4M | 0.97 | |
Vigil Neuroscience (VIGL) | 0.1 | $1.9M | 472k | 4.00 | |
Compugen Ord (CGEN) | 0.1 | $1.7M | 990k | 1.68 | |
Spruce Biosciences (SPRB) | 0.0 | $1.4M | 2.6M | 0.52 | |
Kyverna Therapeutics (KYTX) | 0.0 | $1.3M | 179k | 7.50 | |
Korro Bio (KRRO) | 0.0 | $1.2M | 36k | 33.87 | |
Allakos (ALLK) | 0.0 | $1.2M | 1.2M | 1.00 | |
Biomea Fusion (BMEA) | 0.0 | $815k | 181k | 4.50 | |
Vincerx Pharma Com New (VINC) | 0.0 | $722k | 892k | 0.81 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $483k | 500k | 0.97 | |
Talphera Com New (TLPH) | 0.0 | $282k | 317k | 0.89 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $21k | 134k | 0.16 |